Zinc Metalloproteinases and Amyloid Beta-Peptide Metabolism: The Positive Side of Proteolysis in Alzheimer's Disease
Alzheimer's disease is a neurodegenerative condition characterized by an accumulation of toxic amyloid beta- (A𝛽-)peptides in the brain causing progressive neuronal death. A𝛽-peptides are produced by aspartyl proteinase-mediated cleavage of the larger amyloid precursor protein (APP). In contras...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2011-01-01
|
| Series: | Biochemistry Research International |
| Online Access: | http://dx.doi.org/10.1155/2011/721463 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832565093653544960 |
|---|---|
| author | Mallory Gough Catherine Parr-Sturgess Edward Parkin |
| author_facet | Mallory Gough Catherine Parr-Sturgess Edward Parkin |
| author_sort | Mallory Gough |
| collection | DOAJ |
| description | Alzheimer's disease is a neurodegenerative condition characterized by an accumulation of toxic amyloid beta- (A𝛽-)peptides in the brain causing progressive neuronal death. A𝛽-peptides are produced by aspartyl proteinase-mediated cleavage of the larger amyloid precursor protein (APP). In contrast to this detrimental “amyloidogenic” form of proteolysis, a range of zinc metalloproteinases can process APP via an alternative “nonamyloidogenic” pathway in which the protein is cleaved within its A𝛽 region thereby precluding the formation of intact A𝛽-peptides. In addition, other members of the zinc metalloproteinase family can degrade preformed A𝛽-peptides. As such, the zinc metalloproteinases, collectively, are key to downregulating A𝛽 generation and enhancing its degradation. It is the role of zinc metalloproteinases in this “positive side of proteolysis in Alzheimer's disease” that is discussed in the current paper. |
| format | Article |
| id | doaj-art-4815c007e5104391aab3397f5fd2365d |
| institution | Kabale University |
| issn | 2090-2247 2090-2255 |
| language | English |
| publishDate | 2011-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Biochemistry Research International |
| spelling | doaj-art-4815c007e5104391aab3397f5fd2365d2025-02-03T01:09:25ZengWileyBiochemistry Research International2090-22472090-22552011-01-01201110.1155/2011/721463721463Zinc Metalloproteinases and Amyloid Beta-Peptide Metabolism: The Positive Side of Proteolysis in Alzheimer's DiseaseMallory Gough0Catherine Parr-Sturgess1Edward Parkin2Division of Biomedical and Life Sciences, School of Health and Medicine, Lancaster University, Lancaster LA1 4YQ, UKDivision of Biomedical and Life Sciences, School of Health and Medicine, Lancaster University, Lancaster LA1 4YQ, UKDivision of Biomedical and Life Sciences, School of Health and Medicine, Lancaster University, Lancaster LA1 4YQ, UKAlzheimer's disease is a neurodegenerative condition characterized by an accumulation of toxic amyloid beta- (A𝛽-)peptides in the brain causing progressive neuronal death. A𝛽-peptides are produced by aspartyl proteinase-mediated cleavage of the larger amyloid precursor protein (APP). In contrast to this detrimental “amyloidogenic” form of proteolysis, a range of zinc metalloproteinases can process APP via an alternative “nonamyloidogenic” pathway in which the protein is cleaved within its A𝛽 region thereby precluding the formation of intact A𝛽-peptides. In addition, other members of the zinc metalloproteinase family can degrade preformed A𝛽-peptides. As such, the zinc metalloproteinases, collectively, are key to downregulating A𝛽 generation and enhancing its degradation. It is the role of zinc metalloproteinases in this “positive side of proteolysis in Alzheimer's disease” that is discussed in the current paper.http://dx.doi.org/10.1155/2011/721463 |
| spellingShingle | Mallory Gough Catherine Parr-Sturgess Edward Parkin Zinc Metalloproteinases and Amyloid Beta-Peptide Metabolism: The Positive Side of Proteolysis in Alzheimer's Disease Biochemistry Research International |
| title | Zinc Metalloproteinases and Amyloid Beta-Peptide Metabolism: The Positive Side of Proteolysis in Alzheimer's Disease |
| title_full | Zinc Metalloproteinases and Amyloid Beta-Peptide Metabolism: The Positive Side of Proteolysis in Alzheimer's Disease |
| title_fullStr | Zinc Metalloproteinases and Amyloid Beta-Peptide Metabolism: The Positive Side of Proteolysis in Alzheimer's Disease |
| title_full_unstemmed | Zinc Metalloproteinases and Amyloid Beta-Peptide Metabolism: The Positive Side of Proteolysis in Alzheimer's Disease |
| title_short | Zinc Metalloproteinases and Amyloid Beta-Peptide Metabolism: The Positive Side of Proteolysis in Alzheimer's Disease |
| title_sort | zinc metalloproteinases and amyloid beta peptide metabolism the positive side of proteolysis in alzheimer s disease |
| url | http://dx.doi.org/10.1155/2011/721463 |
| work_keys_str_mv | AT mallorygough zincmetalloproteinasesandamyloidbetapeptidemetabolismthepositivesideofproteolysisinalzheimersdisease AT catherineparrsturgess zincmetalloproteinasesandamyloidbetapeptidemetabolismthepositivesideofproteolysisinalzheimersdisease AT edwardparkin zincmetalloproteinasesandamyloidbetapeptidemetabolismthepositivesideofproteolysisinalzheimersdisease |